Skip to Content

Notice

Notice of Intent To Grant Exclusive License

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble Start Printed Page 37040

AGENCY:

Agricultural Research Service, USDA.

ACTION:

Notice of intent.

SUMMARY:

Notice is hereby given that the U.S. Department of Agriculture, Agricultural Research Service, intends to grant to Zoetis, LLC, of Kalamazoo, Michigan, an exclusive license to U.S. Patent No. 8,765,141, “DEVELOPMENT OF A MARKER FOOT AND MOUTH DISEASE VIRUS VACCINE CANDIDATE THAT IS ATTENUATED IN THE NATURAL HOST”, issued on July 1, 2014, and U.S. Patent No. 9,180,179, “DEVELOPMENT OF A MARKER FOOT AND MOUTH DISEASE VIRUS VACCINE CANDIDATE THAT IS ATTENUATED IN THE NATURAL HOST”, issued on November 10, 2015.

DATES:

Comments must be received on or before August 23, 2017.

ADDRESSES:

Send comments to: USDA, ARS, Office of Technology Transfer, 5601 Sunnyside Avenue, Rm. 4-1174, Beltsville, Maryland 20705-5131.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Brian T. Nakanishi of the Office of Technology Transfer at the Beltsville address given above; telephone: 301-504-5989.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

The Federal Government's patent rights in these inventions are assigned to the United States of America, as represented by the Secretary of Agriculture. It is in the public interest to so license these inventions as Zoetis, LLC, of Kalamazoo, Michigan, has submitted a complete and sufficient application for a license. The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within fifteen (15) days from the date of this published Notice, the Agricultural Research Service receives written evidence and argument which establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7.

Start Signature

Robert Griesbach,

Deputy Assistant Administrator.

End Signature End Supplemental Information

[FR Doc. 2017-16657 Filed 8-7-17; 8:45 am]

BILLING CODE 3410-03-P